Lilly Stops Pediatric Trial of Sepsis Drug (Reuters)


Reuters - Eli Lilly and Co. stopped a study of
its Xigris injection in children because the drug was no more
effective than a placebo for treating severe sepsis, U.S.
regulators and the company said on Thursday.

Read more...